Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Nov 12, 2020 9:15pm

715 Views

Post# 31892558

todays trades

House Positions for C:VXL from 20201112 to 20201112

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
85 Scotia	12,250	1,163	0.095	12	1	0.083	12,238	-1,162
1 Anonymous	12,500	1,125	0.09	2,000	180	0.09	10,500	-945
79 CIBC	34,500	3,277	0.095	28,500	2,692	0.094	6,000	-585
7 TD Sec	35,538	3,300	0.093	31,722	2,883	0.091	3,816	-417
212 Virtu	0			250	23	0.092	-250	23
68 Leede	222	18	0.081	526	49	0.093	-304	31
2 RBC	25,000	2,360	0.094	40,000	3,800	0.095	-15,000	1,440
33 Canaccord	0			17,000	1,615	0.095	-17,000	1,615
TOTAL	120,010	11,243	0.094	120,010	11,243	0.094	0	0